IBEX Limited (IBEX)
(Real Time Quote from BATS)
$13.35 USD
+0.15 (1.14%)
Updated Apr 29, 2024 03:44 PM ET
3-Hold of 5 3
A Value D Growth A Momentum B VGM
Income Statements
Fiscal Year end for IBEX Limited falls in the month of June .
All items in Millions except EPS data.
6/30/23 | 6/30/22 | 6/30/21 | 6/30/20 | 6/30/19 | |
---|---|---|---|---|---|
Sales | 523 | 494 | 444 | 405 | 368 |
Cost Of Goods | 375 | 0 | 0 | 0 | 0 |
Gross Profit | 148 | 494 | 444 | 405 | 368 |
Selling & Adminstrative & Depr. & Amort Expenses | 108 | 464 | 429 | 385 | 361 |
Income After Depreciation & Amortization | 40 | 30 | 15 | 20 | 7 |
Non-Operating Income | 0 | 0 | 1 | 1 | 1 |
Interest Expense | 0 | 9 | 9 | 9 | 8 |
Pretax Income | 40 | 21 | 5 | 10 | -1 |
Income Taxes | 9 | -2 | 2 | 2 | 4 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 32 | 23 | 3 | 8 | -5 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 15 |
Net Income (GAAP) | 32 | 23 | 3 | 8 | 11 |
Depreciation Footnote | 6/30/23 | 6/30/22 | 6/30/21 | 6/30/20 | 6/30/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 59 | 64 | 43 | 45 | 29 |
Depreciation & Amortization (Cash Flow) | 19 | 34 | 28 | 24 | 22 |
Income After Depreciation & Amortization | 40 | 30 | 15 | 20 | 7 |
Earnings Per Share Data | 6/30/23 | 6/30/22 | 6/30/21 | 6/30/20 | 6/30/19 |
---|---|---|---|---|---|
Average Shares | 18.89 | 18.70 | 18.39 | 18.68 | NA |
Diluted EPS Before Non-Recurring Items | 1.76 | 1.24 | 1.28 | 0.84 | NA |
Diluted Net EPS (GAAP) | 1.67 | 1.23 | 0.15 | 0.00 | NA |
Fiscal Year end for IBEX Limited falls in the month of June .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | 132.63 | 124.61 | 124.26 | 131.60 |
Cost Of Goods | NA | 95.88 | 88.20 | 374.99 | 0.00 |
Gross Profit | NA | 36.75 | 36.41 | 124.26 | 131.60 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 29.81 | 28.08 | -195.87 | 116.21 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | 6.94 | 8.33 | 320.13 | 15.39 |
Non-Operating Income | NA | 0.51 | 0.59 | 0.00 | 0.00 |
Interest Expense | NA | 0.11 | 0.10 | -5.58 | 1.78 |
Pretax Income | NA | 7.35 | 8.81 | 17.39 | 13.61 |
Income Taxes | NA | 1.27 | 1.39 | 3.68 | 1.91 |
Minority Interest | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | 6.08 | 7.43 | 13.71 | 11.70 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | 6.08 | 7.43 | 13.71 | 11.70 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | 18.44 | 18.90 | 18.99 | 19.05 |
Diluted EPS Before Non-Recurring Items | NA | 0.37 | 0.35 | 0.30 | 0.52 |
Diluted Net EPS (GAAP) | NA | 0.33 | 0.39 | 0.73 | 0.61 |